CD274 and neoplasm: PD-L1 is a crucial regulator of tumor glucose metabolism, as demonstrated by studies indicating that inhibition of PD-L1 disrupts glycolysis by suppressing mTOR activity and decreasing glycolytic enzyme expression [122].